Insider Bernocchi Reports Change in Accendra Health Ownership

TL;DR

**Insider Bernocchi reported a change in ownership of Accendra Health shares.**

AI Summary

This Form 4 filing indicates that Perry A. Bernocchi, a reporting insider, filed a statement of changes in beneficial ownership of securities on March 24, 2026, for Accendra Health Inc./VA/. The filing reports activity as of March 20, 2026. While the specific transaction details (buy/sell, share count, price) are not provided in this summary, the filing itself signals that an insider's holdings have changed. This matters to investors because insider transactions can sometimes signal management's confidence (or lack thereof) in the company's future prospects.

Why It Matters

Insider transaction filings like this can offer a glimpse into how company executives and directors view their own stock, which can influence investor sentiment.

Risk Assessment

Risk Level: low — This filing is purely informational, reporting a change in insider ownership, and does not inherently pose a direct financial risk.

Analyst Insight

A smart investor would look up the full Form 4 document to understand the specific nature (buy or sell), quantity, and price of the shares involved in Bernocchi Perry A's transaction to gauge insider sentiment.

Key Players & Entities

• Bernocchi Perry A (person) — Reporting insider
• Accendra Health Inc/VA/ (company) — Issuer of securities
• March 24, 2026 (date) — Filing date
• March 20, 2026 (date) — Period of report

Forward-Looking Statements

• The full details of Bernocchi Perry A's transaction (buy/sell, quantity, price) will be available in the complete form4.html document. (Bernocchi Perry A) — high confidence, target: 2026-03-24

FAQ

Filing Documents

• form4.html (4)
• form4.xml (4) — 3KB
• 0000075252-26-000014.txt ( ) — 5KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Bernocchi Perry A (Last) (First) (Middle) ACCENDRA HEALTH INC. 4435 WATERFRONT DRIVE (Street) GLEN ALLEN VIRGINIA 23060 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol ACCENDRA HEALTH INC/VA/ [ ACH ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP, Chief Operating Officer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/20/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/20/2026 F 20,841 (1) D $ 2.03 321,821 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Perry A. Bernocchi, by Rosemarie France POA 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR